JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB79414

Anti-CD79a antibody [EP3618]

Be the first to review this product! Submit a review

|

(11 Publications)

Rabbit Recombinant Monoclonal CD79A antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 11 publications.

View Alternative Names

CD79a, IGA, MB1, CD79A, B-cell antigen receptor complex-associated protein alpha chain, Ig-alpha, MB-1 membrane glycoprotein, Membrane-bound immunoglobulin-associated protein, Surface IgM-associated protein

10 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)

ab79414 showing positive staining in Normal tonsil tissue. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)

ab79414 showing positive staining in Normal spleen tissue.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-CD79a antibody [EP3618] (AB79414)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-CD79a antibody [EP3618] (AB79414)

Immunocytochemistry/Immunofluorescence analysis of RAMOS (human Burkitt's lymphoma) cells labelling CD79a with purified ab79414 at 1/500. Cells were fixed with 4% Paraformaldehyde and permeabilized with 0.1% Triton X-100. ab150077, Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. Nuclei were counterstained with DAPI (blue).

Secondary Only Control : PBS was used instead of the primary antibody as the negative control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)

ab79414 at 1/100 dilution staining CD79a in paraffin-embedded human tonsil tissue by Immunohistochemistry. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Western blot - Anti-CD79a antibody [EP3618] (AB79414)
  • WB

Lab

Western blot - Anti-CD79a antibody [EP3618] (AB79414)

False colour image of Western blot : Anti-CD79a antibody [EP3618] staining at 1/5000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab79414 was shown to bind specifically to CD79a. A band was observed at 40-50 kDa in wild-type Raji cell lysates with no signal observed at this size in CD79A knockout cell line ab274911 (knockout cell lysate ab281361). To generate this image, wild-type and CD79A knockout Raji cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-CD79a antibody [EP3618] (ab79414) at 1/5000 dilution

Lane 1:

Wild-type Raji cell lysate at 20 µg

Lane 2:

CD79A knockout Raji cell lysate at 20 µg

Lane 2:

Western blot - Human CD791 knockout Raji cell line (<a href='/en-us/products/cell-lines/human-cd791-knockout-raji-cell-line-ab274911'>ab274911</a>)

Lane 3:

Daudi cell lysate at 20 µg

Lane 4:

HAP1 cell lysate at 20 µg

Predicted band size: 25 kDa

Observed band size: 40-50 kDa

false

Western blot - Anti-CD79a antibody [EP3618] (AB79414)
  • WB

Unknown

Western blot - Anti-CD79a antibody [EP3618] (AB79414)

All lanes:

Western blot - Anti-CD79a antibody [EP3618] (ab79414) at 1/10000 dilution

Lane 1:

Raji cell lysate at 10 µg

Lane 2:

Daudi cell lysate at 10 µg

Lane 3:

Human tonsil tissue lysate at 10 µg

Lane 4:

Human spleen tissue lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 25 kDa

Observed band size: 44-48 kDa

false

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)

ab79414 showing negative staining in Normal colon tissue.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)

ab79414 showing negative staining in Normal heart tissue.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD79a antibody [EP3618] (AB79414)

ab79414 showing negative staining in Normal brain tissue. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

OI-RD Scanning - Anti-CD79a antibody [EP3618] (AB79414)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-CD79a antibody [EP3618] (AB79414)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

  • Carrier free

    Anti-CD79a antibody [EP3618] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EP3618

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/5000 - 1/20000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Product details

Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purity
Tissue culture supernatant
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD79a also known as Ig-alpha or MB-1 is a component of the B cell antigen receptor (BCR) complex. It is a transmembrane protein with a molecular mass of approximately 47 kDa. CD79a is part of a heterodimer with CD79b and is mainly expressed on the surface of B lymphocytes. This protein plays a critical mechanical role in signaling transduction through the BCR by associating with membrane-bound immunoglobulin molecules helping to initiate the immune response upon antigen binding.
Biological function summary

This protein acts as an essential mediator in the immune system. CD79a together with CD79b forms part of the BCR complex critical for B cell development and maturation. The BCR complex activates signaling cascades that influence B cell fate decisions such as proliferation differentiation and apoptosis. By transmitting signals from the BCR CD79a helps regulate these cellular functions necessary for efficient immune defense.

Pathways

CD79a plays a pivotal role in the B cell receptor signaling pathway. This pathway involves signaling molecules such as spleen tyrosine kinase (SYK) and phosphoinositide 3-kinase (PI3K) which are activated upon BCR engagement. CD79a acts in concert with other proteins including CD79b and the IgM receptor facilitating downstream signaling cascades that ensure proper B cell responses. Its role is important for linking extracellular antigen recognition to intracellular signaling events.

CD79a is significant in conditions like B cell lymphomas and certain immunodeficiencies. Abnormal expression or mutations in CD79a are associated with some types of non-Hodgkin lymphoma. The protein's interaction with CD79b is particularly relevant as alterations in these proteins' function or expression can impact B cell development and lead to pathogenesis in lymphoproliferative disorders. Consequently CD79a serves as an important biomarker and potential therapeutic target in these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Required in cooperation with CD79B for initiation of the signal transduction cascade activated by binding of antigen to the B-cell antigen receptor complex (BCR) which leads to internalization of the complex, trafficking to late endosomes and antigen presentation. Also required for BCR surface expression and for efficient differentiation of pro- and pre-B-cells. Stimulates SYK autophosphorylation and activation. Binds to BLNK, bringing BLNK into proximity with SYK and allowing SYK to phosphorylate BLNK. Also interacts with and increases activity of some Src-family tyrosine kinases. Represses BCR signaling during development of immature B-cells.
See full target information CD79A

Publications (11)

Recent publications for all applications. Explore the full list and refine your search

Cell reports. Medicine 5:101851 PubMed39657667

2024

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.

Applications

Unspecified application

Species

Unspecified reactive species

Jiaying Toh,Andrea J Reitsma,Tetsuya Tajima,Sheren F Younes,Chimere Ezeiruaku,Kayla C Jenkins,Josselyn K Peña,Shuchun Zhao,Xi Wang,Esmond Y Z Lee,Marla C Glass,Laurynas Kalesinskas,Ananthakrishnan Ganesan,Irene Liang,Joy A Pai,James T Harden,Francesco Vallania,Edward A Vizcarra,Govind Bhagat,Fiona E Craig,Steven H Swerdlow,Julie Morscio,Daan Dierickx,Thomas Tousseyn,Ansuman T Satpathy,Sheri M Krams,Yasodha Natkunam,Purvesh Khatri,Olivia M Martinez

Nature genetics 56:1712-1724 PubMed39048792

2024

Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression.

Applications

Unspecified application

Species

Unspecified reactive species

Amin Abedini,Jonathan Levinsohn,Konstantin A Klötzer,Bernhard Dumoulin,Ziyuan Ma,Julia Frederick,Poonam Dhillon,Michael S Balzer,Rojesh Shrestha,Hongbo Liu,Steven Vitale,Andi M Bergeson,Kishor Devalaraja-Narashimha,Paola Grandi,Tanmoy Bhattacharyya,Erding Hu,Steven S Pullen,Carine M Boustany-Kari,Paolo Guarnieri,Anil Karihaloo,Daniel Traum,Hanying Yan,Kyle Coleman,Matthew Palmer,Lea Sarov-Blat,Lori Morton,Christopher A Hunter,Klaus H Kaestner,Mingyao Li,Katalin Susztak

Molecular medicine (Cambridge, Mass.) 29:145 PubMed37884883

2023

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.

Applications

Unspecified application

Species

Unspecified reactive species

Yi Zhao,Yanjun Wei,Lingjia Fan,Yuanliu Nie,Jianan Li,Renya Zeng,Jixian Li,Xiang Zhan,Lingli Lei,Zhichao Kang,Jiaxin Li,Wentao Zhang,Zhe Yang

Frontiers in immunology 14:1166497 PubMed37234171

2023

Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Taiyu Shang,Tianyi Jiang,Tao Lu,Hui Wang,Xiaowen Cui,Yufei Pan,Mengyou Xu,Mengmiao Pei,Zhiwen Ding,Xiaofan Feng,Yunkai Lin,Xin Li,Yexiong Tan,Feiling Feng,Hui Dong,Hongyang Wang,Liwei Dong

Diabetic medicine : a journal of the British Diabetic Association 40:e15106 PubMed37014274

2023

Lymphocytes regulate expression of the SARS-CoV-2 cell entry factor ACE2 in the pancreas of T2DM patients.

Applications

Unspecified application

Species

Unspecified reactive species

Peng Zhang,Chang-Bo Zheng,Xiao-Yu Liu,Xiaowei Zhang,Lingyan Huang,Xianhai Zeng

iScience 26:106140 PubMed36879799

2023

Altered B cell immunoglobulin signature exhibits potential diagnostic values in human colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Rui-Xian Liu,Chuangyu Wen,Weibiao Ye,Yewei Li,Junxiong Chen,Qian Zhang,Weiqian Li,Wanfei Liang,Lili Wei,Jingdan Zhang,Ka-Wo Chan,Xueqin Wang,Xiangling Yang,Huanliang Liu

Frontiers in cell and developmental biology 9:758339 PubMed34805166

2021

Papillary Thyroid Carcinoma Landscape and Its Immunological Link With Hashimoto Thyroiditis at Single-Cell Resolution.

Applications

Unspecified application

Species

Unspecified reactive species

Jun Pan,Fang Ye,Chengxuan Yu,Qinsheng Zhu,Jiaqi Li,Yaohui Zhang,Hedi Tian,Yunjin Yao,Minjie Zhu,Yibin Shen,Feng Zhu,Yingying Wang,Xinhui Zhou,Guoji Guo,Yijun Wu

Frontiers in oncology 10:609839 PubMed33585230

2021

Whole-Exome Sequencing Reveals New Potential Mutations Genes for Primary Mucosa-Associated Lymphoid Tissue Lymphoma Arising From the Kidney.

Applications

Unspecified application

Species

Unspecified reactive species

Shuang Wen,Tianqing Liu,Hongshuo Zhang,Xu Zhou,Huidan Jin,Man Sun,Zhifei Yun,Hong Luo,Ze Ni,Rui Zhao,Bo Fan

eLife 10: PubMed33393902

2021

Defining human mesenchymal and epithelial heterogeneity in response to oral inflammatory disease.

Applications

Unspecified application

Species

Unspecified reactive species

Ana J Caetano,Val Yianni,Ana Volponi,Veronica Booth,Eleanor M D'Agostino,Paul Sharpe

Molecular and clinical oncology 8:729-732 PubMed29732155

2018

Misdiagnosis of primary pleural DLBCL as tuberculosis: A case report and literature review.

Applications

Unspecified application

Species

Unspecified reactive species

Xinmei Yang,Xiaofang Xu,Binbin Song,Qiang Zhou,Ying Zheng
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com